Extra-articular manifestations in a community-based sample of patients with rheumatoid arthritis: Incidence and relationship to treatment with TNF inhibitors

Scandinavian Journal of Rheumatology

Volumn 41, Issue 6, 2012, Pages 434-437

  Nyhall Wahlin B M ^a   Petersson, I F ^b   Jacobsson, C ^b   Geborek, P ^b   Nilsson, J A ^b   Nilsson, K ^b   Jacobsson, L T H ^b   Turesson, C ^b  

^a FALUN HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY ASSESSMENT; DEATH; DISEASE SEVERITY; DRUG EXPOSURE; DRUG WITHDRAWAL; EPISCLERITIS; EXTRAARTICULAR RHEUMATOID ARTHRITIS; FELTY SYNDROME; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIGRATION; NEUROPATHY; PERICARDITIS; PLEURISY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK REDUCTION; SCLERITIS; VASCULITIS;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERICARDITIS; PLEURISY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 84869407304     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.695803     Document Type: Article

References (15)

1. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38:668-74. (Pubitemid 29507338)
2. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29: 62-7. (Pubitemid 34041860)
3. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7. (Pubitemid 36886405)
4. Turesson C, McClelland RL, Christianson TJ, Matteson EL. No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum 2004;50: 3729-31. (Pubitemid 39488703)
5. Myasoedova E, Crowson CS, Turesson C, Gabriel SE, Matteson EL. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: A population-based study. J Rheumatol 2011;38:983-9.
6. Bartels CM, Bell CL, Shinki K, Rosenthal A, Bridges AJ. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford) 2010;49:1670-5.
7. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, et al. Anti-tumor necrosis factor-alpha therapyinduced vasculitis: case series. J Rheumatol 2003;30:2287-91. (Pubitemid 37221866)
8. Chatterjee S. Severe interstitial pneumonitis associated with infliximab therapy. Scand J Rheumatol 2004;33:276-7. (Pubitemid 39180174)
9. Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2004;33:65-72. (Pubitemid 38437967)
10. Nyhall-Wahlin BM, Petersson IF, Nilsson JA, Jacobsson LT, Turesson C. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis. Rheumatology (Oxford) 2009;48:416-20.
11. Geborek P, Nitelius E, Noltorp S, Petri H, Jacobsson L, Larsson L, et al. Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales. Ann Rheum Dis 2005;64:1805-7. (Pubitemid 41667171)
12. Lindsay K, Melsom R, Jacob BK, Mestry N. Acute progression of interstitial lung disease: A complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment. Rheumatology (Oxford) 2006;45:1048-9. (Pubitemid 44283069)
13. Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol 2007;36:172-8. (Pubitemid 47174545)
14. Puechal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E, et al. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis 2008;67:880-4. (Pubitemid 351829393)
15. SoderlinMK, Lindroth Y, Turesson C, Jacobsson LT. A more active treatment has profound effects on the health status of rheumatoid arthritis (RA) patients: results from a population-based RA register in Malmo, Sweden, 1997-2005. Scand J Rheumatol 2010;39:206-11.